In astroglial cells ␤-amyloid peptides (␤A) induce a reactive phenotype and increase expression of NO synthase. Here we show that treatment of rat brain astrocytes with ␤A decreases their capacity to accumulate cyclic GMP (cGMP) in response to NO as a result of a decreased expression of soluble guanylyl cyclase (sGC) at the protein and mRNA levels. Potentiation of ␤A-induced NO formation by interferon-␥ did not result in a larger decrease in cGMP formation and inhibition of NO synthase failed to reverse down-regulation of sGC, indicating that NO is not involved. The ␤A effect was prevented by the protein synthesis inhibitor cycloheximide. Intracerebral ␤A injection also decreased sGC ␤1 subunit mRNA levels in adult rat hippocampus and cerebellum. A loss of sGC in reactive astrocytes surrounding ␤-amyloid plaques could be a mechanism to prevent excess signalling via cGMP at sites of high NO production. © 2002 Elsevier Science (USA)
INTRODUCTION
Reactive astroglial and microglial cells are key cellular elements in the neuroinflammation observed in Alzheimer's disease (AD) and other neurodegenerative conditions (Eddleston and Mucke, 1993; Gonzá-lez-Scarano and Baltuch, 1999) . In AD brains, reactive astrocytes are associated with amyloid plaques at early stages of the disease (Pike et al., 1995) and have been shown to express nitric oxide synthase type 2 (NOS-2) (Wallace et al., 1997) . The highly reactive derivative of NO peroxynitrite is formed at these sites and appears to be an important source of oxidative stress leading to neuronal death (Smith et al., 1997; Pappolla et al., 1998) .
␤-Amyloid peptides (␤A) are capable of activating rodent glial cells in culture leading to induction of NOS-2 expression in both astroglia and microglia and release of inflammatory cytokines mostly from microglia (Pike et al., 1994; Meda et al., 1995; Goodwin et al., 1995; Rossi et al., 1996; Hu et al., 1998) . In rat cortical glial cultures, microglial derived interleukin-1␤ (IL-1␤) appears to be responsible for NOS-2 induction in astrocytes (Akama and Van Eldik, 2000) .
In the normal CNS moderate amounts of NO are generated in neurones and in astrocytes by constitutive nitric oxide synthases (NOS-1 and NOS-3) stimulated by neurotransmitters that increase intracellular Ca 2ϩ (reviews in Zhang and Synder, 1995; Fö rstermann et al., 1998; Baltrons and García, 2001) . Soluble guanylyl cyclase (sGC; GTP pyrophosphate-lyase (cyclizing), EC 4.6.1.2) is the major physiological target for NO and cyclic GMP (cGMP) the mediator of important neuromodulatory actions of NO in synaptic plasticity, brain development, neuroendocrine secretion, etc. (reviews in Garthwaite and Boulton, 1995; Zhang and Synder, 1995) . Very little is known about the regulation of cGMP formation under neuropathological conditions associated with chronic inflammation and excess NO production by NOS-2 in activated glial cells and/or infiltrated macrophages. We have recently demonstrated that long-term treatment of rat brain astroglial cells with lipopolysaccharide (LPS), condition that induces astroglial reactivity and NOS-2 
